These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10337136)

  • 21. Will sublingual immunotherapy become an approved treatment method in the United States?
    Cox L; Compalati E; Canonica W
    Curr Allergy Asthma Rep; 2011 Feb; 11(1):4-6. PubMed ID: 20976576
    [No Abstract]   [Full Text] [Related]  

  • 22. Four herbs.
    Harv Mens Health Watch; 2000 Aug; 5(1):5-7. PubMed ID: 10927656
    [No Abstract]   [Full Text] [Related]  

  • 23. From aspartame to Xenical. A look at the FDA review process.
    Trissler RJ
    J Am Diet Assoc; 1999 Jul; 99(7):797-8. PubMed ID: 10405675
    [No Abstract]   [Full Text] [Related]  

  • 24. Be wary of recommending off-label use of meds.
    Luttrull S
    Adv Nurse Pract; 2001 Feb; 9(2):18. PubMed ID: 12416047
    [No Abstract]   [Full Text] [Related]  

  • 25. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jun; 72(121):34751-958. PubMed ID: 17674484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Education or promotion?: Industry-sponsored continuing medical education (CME) as a center for the core/commercial speech debate.
    Chen P;
    Food Drug Law J; 2003; 58(3):473-509. PubMed ID: 14626981
    [No Abstract]   [Full Text] [Related]  

  • 27. Herbal medicine.
    Wollschlaeger BA
    N Engl J Med; 2003 Apr; 348(15):1498-501; author reply 1498-501. PubMed ID: 12691064
    [No Abstract]   [Full Text] [Related]  

  • 28. Off-label pharmaceutical use: balancing information, risks, and benefits.
    Kozma CM
    Manag Care Interface; 2004 Jan; 17(1):29-30. PubMed ID: 15035597
    [No Abstract]   [Full Text] [Related]  

  • 29. Patient education series. Herbal supplements.
    Nursing; 2004 Dec; 34(12):52-3. PubMed ID: 15617217
    [No Abstract]   [Full Text] [Related]  

  • 30. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
    Novak E; Allen PJ
    Pediatr Nurs; 2007; 33(1):64-70. PubMed ID: 17411005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remedies from nature make new health claims.
    Fischer JS
    US News World Rep; 2000 Feb; 128(6):60. PubMed ID: 11184135
    [No Abstract]   [Full Text] [Related]  

  • 32. Essays in public health and preventive medicine. A call to Pharms: the need for tighter FDA regulation of the neutraceutical industry.
    Dobrin J
    Mt Sinai J Med; 2006 Mar; 73(2):565-6. PubMed ID: 16685816
    [No Abstract]   [Full Text] [Related]  

  • 33. Alternative medicine--the case of herbal remedies.
    Oz M; Rose E; Lemole GM
    N Engl J Med; 1999 Feb; 340(7):564-5; author reply 566. PubMed ID: 10026041
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA perspectives on supplement use by patients on antithrombotic therapy: dietary supplement regulatory overview.
    Woo JJ
    Thromb Res; 2005; 117(1-2):193-6; discussion 201-7. PubMed ID: 16253311
    [No Abstract]   [Full Text] [Related]  

  • 35. Readers' and author's responses to "Evidence-based standards should apply to dietary supplements, too".
    Hendriksen P
    MedGenMed; 2007; 9(4):21; author reply 21. PubMed ID: 18320625
    [No Abstract]   [Full Text] [Related]  

  • 36. From herbal Prozac to Mark McGwire's tonic: how the Dietary Supplement Health and Education Act changed the regulatory landscape for health products.
    Kaczka KA
    J Contemp Health Law Policy; 2000; 16(2):463-99. PubMed ID: 10970182
    [No Abstract]   [Full Text] [Related]  

  • 37. What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval.
    Dodge T; Kaufman A
    Health Psychol; 2007 Jul; 26(4):513-7. PubMed ID: 17605572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA regulation of ingredients in dietary supplements after passage of the Dietary Supplement Health and Education Act of 1994: an update.
    McNamara SH
    Food Drug Law J; 1996; 51(2):313-8. PubMed ID: 11822323
    [No Abstract]   [Full Text] [Related]  

  • 39. Symposium: Self-directed learning and physicians' practice changes: concepts, research and implications for CME.
    Bashook P; Meyer TC; Richards RK; Long RJ; Parboosingh J
    Res Med Educ; 1986; 25():329-38. PubMed ID: 3641585
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA perspectives on supplement use by patients on antithrombotic therapy.
    Kim MJ
    Thromb Res; 2005; 117(1-2):197-200; discussion 201-7. PubMed ID: 16188297
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.